Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Sponsor: Lindsay Maguire, MD
Summary
There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.
Official title: Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-05-01
Completion Date
2026-04
Last Updated
2025-07-10
Healthy Volunteers
No
Conditions
Interventions
Ketamine
Patients will receive 0.2mg/kg of IV ketamine
Locations (2)
University of Kansas Strawberry Hill Campus
Kansas City, Kansas, United States
University of Kansas Medical Center Emergency Department
Kansas City, Kansas, United States